Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Worleybird Innovation Works. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Worleybird Innovation Works or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The GLP-1 Alzheimer's Myth: When Headlines Crash Into Reality

18:19
 
Share
 

Manage episode 524346740 series 3700920
Content provided by Worleybird Innovation Works. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Worleybird Innovation Works or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

A shocking medical headline claimed weight loss drugs like Ozempic could slash Alzheimer's risk by 45% - but what if the story was too good to be true? This episode unravels a critical medical mystery, exposing how a sensational claim derived from observational studies completely fell apart when rigorous clinical trials were conducted. Listeners will discover the stark difference between promising associations and actual medical proof, learning how media headlines can dramatically misrepresent scientific research. We'll break down why a 45% risk reduction reported in May 2025 became a complete failure by November, revealing the crucial importance of understanding study types and not jumping to premature conclusions about medical treatments. A quick note—the opinions and analysis shared on Truth Seekers are our own interpretations of published research and should not be used as medical, financial, or professional advice. Always consult qualified professionals for decisions affecting your health or wellbeing.

  continue reading

17 episodes

Artwork
iconShare
 
Manage episode 524346740 series 3700920
Content provided by Worleybird Innovation Works. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Worleybird Innovation Works or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

A shocking medical headline claimed weight loss drugs like Ozempic could slash Alzheimer's risk by 45% - but what if the story was too good to be true? This episode unravels a critical medical mystery, exposing how a sensational claim derived from observational studies completely fell apart when rigorous clinical trials were conducted. Listeners will discover the stark difference between promising associations and actual medical proof, learning how media headlines can dramatically misrepresent scientific research. We'll break down why a 45% risk reduction reported in May 2025 became a complete failure by November, revealing the crucial importance of understanding study types and not jumping to premature conclusions about medical treatments. A quick note—the opinions and analysis shared on Truth Seekers are our own interpretations of published research and should not be used as medical, financial, or professional advice. Always consult qualified professionals for decisions affecting your health or wellbeing.

  continue reading

17 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play